203 related articles for article (PubMed ID: 8678876)
1. TGF-alpha immunoreactivity in laryngeal carcinoma: lack of prognostic value and correlation to EGF-receptor expression.
Lee CS; Redshaw A; Boag G
Aust N Z J Surg; 1996 Jul; 66(7):464-8. PubMed ID: 8678876
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor receptor immunoreactivity in human laryngeal squamous cell carcinoma.
Lee CS; Redshaw A; Boag G
Pathology; 1997 Aug; 29(3):251-4. PubMed ID: 9271009
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor alpha immunoreactivity in human gallbladder and extrahepatic biliary tract tumours.
Lee CS
Eur J Surg Oncol; 1998 Feb; 24(1):38-42. PubMed ID: 9542514
[TBL] [Abstract][Full Text] [Related]
4. nm23-H1 protein immunoreactivity in laryngeal carcinoma.
Lee CS; Redshaw A; Boag G
Cancer; 1996 Jun; 77(11):2246-50. PubMed ID: 8635091
[TBL] [Abstract][Full Text] [Related]
5. Expression of epidermal growth factor receptor in laryngeal dysplasia and carcinoma.
Miyaguchi M; Olofsson J; Hellquist HB
Acta Otolaryngol; 1990; 110(3-4):309-13. PubMed ID: 2239223
[TBL] [Abstract][Full Text] [Related]
6. Patterns of expressions of transforming growth factor and epidermal growth factor receptor in squamous cell lesions of the urinary bladder.
Tungekar MF; Linehan J
J Clin Pathol; 1998 Aug; 51(8):583-7. PubMed ID: 9828815
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of EGFR and TGF-alpha in early laryngeal cancer treated with radiotherapy.
Wen QH; Miwa T; Yoshizaki T; Nagayama I; Furukawa M; Nishijima H
Laryngoscope; 1996 Jul; 106(7):884-8. PubMed ID: 8667988
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of cyclooxygenase-2 in laryngeal squamous cell carcinoma.
Ranelletti FO; Almadori G; Rocca B; Ferrandina G; Ciabattoni G; Habib A; Galli J; Maggiano N; Gessi M; Lauriola L
Int J Cancer; 2001 Nov; 95(6):343-9. PubMed ID: 11668514
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor alpha and epidermal growth factor in laryngeal carcinomas demonstrated by immunohistochemistry.
Christensen ME; Therkildsen MH; Poulsen SS; Bretlau P
Acta Otolaryngol; 1993 Jul; 113(4):563-7. PubMed ID: 7691024
[TBL] [Abstract][Full Text] [Related]
10. Comparative study in the expression of p53, EGFR, TGF-alpha, and cyclin D1 in verrucous carcinoma, verrucous hyperplasia, and squamous cell carcinoma of head and neck region.
Wu M; Putti TC; Bhuiya TA
Appl Immunohistochem Mol Morphol; 2002 Dec; 10(4):351-6. PubMed ID: 12607604
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of transforming growth factor-alpha and epidermal growth factor receptor, but not epidermal growth factor, in exocrine pancreatic tumours in hamsters.
Visser CJ; Bruggink AH; Korc M; Kobrin MS; de Weger RA; Seifert-Bock I; van Blokland WT; van Garderen-Hoetmer A; Woutersen RA
Carcinogenesis; 1996 Apr; 17(4):779-85. PubMed ID: 8625491
[TBL] [Abstract][Full Text] [Related]
12. Immunocytochemical study of epidermal growth factor receptor, transforming growth factor alpha, and "squamous differentiation" in human endometrial carcinoma.
Santini D; Ceccarelli C; Martinelli GN; Leone O; Marabini A; Orlandi C; Mancini AM
Hum Pathol; 1994 Dec; 25(12):1319-23. PubMed ID: 7528164
[TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of TGF-alpha and EGFR mRNA in laryngeal carcinoma tissues.
Yang B; Li F
Chin Med J (Engl); 1999 Dec; 112(12):1088-92. PubMed ID: 11721445
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of transforming growth factor-alpha in human esophageal carcinoma. Implication for the autocrine proliferation.
Iihara K; Shiozaki H; Tahara H; Kobayashi K; Inoue M; Tamura S; Miyata M; Oka H; Doki Y; Mori T
Cancer; 1993 May; 71(10):2902-9. PubMed ID: 8490817
[TBL] [Abstract][Full Text] [Related]
15. Abnormalities in type IV collagen immunoreactivity in human laryngeal cancers.
Lee CS; Redshaw A; Boag G
Pathology; 1996 May; 28(2):135-8. PubMed ID: 8743818
[TBL] [Abstract][Full Text] [Related]
16. The EGF receptor system in head and neck carcinomas and normal tissues. Immunohistochemical and quantitative studies.
Christensen ME
Dan Med Bull; 1998 Apr; 45(2):121-34. PubMed ID: 9587699
[TBL] [Abstract][Full Text] [Related]
17. Expression of biomarkers (p53, transforming growth factor alpha, epidermal growth factor receptor, c-erbB-2/neu and the proliferative cell nuclear antigen) in oropharyngeal squamous cell carcinomas.
Ibrahim SO; Lillehaug JR; Johannessen AC; Liavaag PG; Nilsen R; Vasstrand EN
Oral Oncol; 1999 May; 35(3):302-13. PubMed ID: 10621852
[TBL] [Abstract][Full Text] [Related]
18. Immunoreactive transforming growth factor alpha and epidermal growth factor in oral squamous cell carcinomas.
Christensen ME; Therkildsen MH; Poulsen SS; Bretlau P
J Pathol; 1993 Mar; 169(3):323-8. PubMed ID: 8492225
[TBL] [Abstract][Full Text] [Related]
19. Co-expression of epidermal growth factor receptor and transforming growth factor-alpha predicts worse prognosis in breast-cancer patients.
Umekita Y; Ohi Y; Sagara Y; Yoshida H
Int J Cancer; 2000 Nov; 89(6):484-7. PubMed ID: 11102891
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical analysis of phosphotyrosine signal transducer and activator of transcription 3 and epidermal growth factor receptor autocrine signaling pathways in head and neck cancers and metastatic lymph nodes.
Seethala RR; Gooding WE; Handler PN; Collins B; Zhang Q; Siegfried JM; Grandis JR
Clin Cancer Res; 2008 Mar; 14(5):1303-9. PubMed ID: 18316548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
